<
>
Methotrexate (59-05-2)
Product Summary
Methotrexate (59-05-2), 98% assay, CP/EP/in-house specs. Versatile immunosuppressant for cancer, rheumatoid arthritis & autoimmune diseases. 2-year shelf life, 25kg/drum.
Product Custom Attributes
CAS:
59-05-2
Specification:
CP, EP, In-house, As Required
M.F.:
C20H22N8O5
M.W.:
454.45
Assay:
98%
Shelf Life:
2 Years
Package:
25kg/drum
Highlight:
Methotrexate 59-05-2
,Methotrexate CAS: 59-05-2
,rheumatoid Methotrexate
Trading Properties
Stock:
In Stock
Shipping Method:
AIR, Express
Description:
CAS: 59-05-2; anti-tumor ; arthritis; rheumatoid
Payment Terms:
L/C,T/T
Product Description
Methotrexate (59-05-2)
Methotrexate is a cytotoxic drug used for cancer treatment. To reduce its cytotoxicity, it can be administered in conjunction with calcium leucovorin. This medication is primarily indicated for the treatment of acute lymphocytic leukemia, breast cancer, malignant mole and choriocarcinoma, head and neck cancer, bone cancer, leukemia, spinal cord meningeal infiltration, lung cancer, reproductive system cancer, liver cancer, as well as refractory psoriasis vulgaris, dermatomyositis, body myositis, ankylosing spondylitis inflammation, Crohn's disease, psoriasis and psoriatic arthritis, Behcet's disease and various autoimmune conditions.
As an immunosuppressant, Methotrexate is effective in easing rheumatism processes and demonstrates particularly excellent efficacy in treating synovial inflammation of rheumatoid arthritis. It is among the most frequently prescribed drugs for treating rheumatoid diseases.
Product Specifications
| Product Name: | Methotrexate |
| CAS No.: | 59-05-2 |
| Assay: | 98% |
| Specification: | CP, EP, In-house, as required |
| Molecular Formula: | C20H22N8O5 |
| Molecular Weight: | 454.45 |
| Shelf Life: | 2 Years |
| Package: | 25kg/drum |
Product Images
Contact Our Experts And Get A Free Consultation!
Our mission is to offer "High Quality" & "Good Service" & "Fast Delivery" to help our clients to gain more profits.
